nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—CYP3A4—bone cancer	0.714	1	CbGaD
Estropipate—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00379	0.0448	CbGpPWpGaD
Estropipate—ESR1—LKB1 signaling events—ETV4—bone cancer	0.00332	0.0392	CbGpPWpGaD
Estropipate—ESR1—Signaling events mediated by HDAC Class II—BCOR—bone cancer	0.00326	0.0385	CbGpPWpGaD
Estropipate—ESR2—Nuclear Receptors—NR1I2—bone cancer	0.00289	0.0341	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—FEV—bone cancer	0.00276	0.0326	CbGpPWpGaD
Estropipate—Ethinyl Estradiol—NR1I2—bone cancer	0.00269	0.319	CrCbGaD
Estropipate—ESR2—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00229	0.027	CbGpPWpGaD
Estropipate—Estradiol—NR1I2—bone cancer	0.00177	0.21	CrCbGaD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—GNA11—bone cancer	0.00175	0.0207	CbGpPWpGaD
Estropipate—ESR1—Signaling events mediated by HDAC Class II—TUBB2A—bone cancer	0.00154	0.0182	CbGpPWpGaD
Estropipate—ESR1—Nuclear Receptors—NR1I2—bone cancer	0.00146	0.0172	CbGpPWpGaD
Estropipate—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00146	0.0172	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—FOLR1—bone cancer	0.00142	0.0168	CbGpPWpGaD
Estropipate—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00139	0.0165	CbGpPWpGaD
Estropipate—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.00139	0.0164	CbGpPWpGaD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—IGF1R—bone cancer	0.00128	0.0151	CbGpPWpGaD
Estropipate—Exemestane—CYP3A4—bone cancer	0.00125	0.149	CrCbGaD
Estropipate—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00125	0.0147	CbGpPWpGaD
Estropipate—ESR2—Ovarian Infertility Genes—CDK4—bone cancer	0.0012	0.0142	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—ZNF77—bone cancer	0.00117	0.0138	CbGpPWpGaD
Estropipate—ESR1—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00115	0.0136	CbGpPWpGaD
Estropipate—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000962	0.0114	CbGpPWpGaD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—bone cancer	0.000933	0.011	CbGpPWpGaD
Estropipate—Estramustine—CYP3A4—bone cancer	0.000906	0.107	CrCbGaD
Estropipate—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000905	0.0107	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—GNA11—bone cancer	0.000884	0.0104	CbGpPWpGaD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—MMP2—bone cancer	0.000822	0.00971	CbGpPWpGaD
Estropipate—ESR1—Estrogen Receptor Pathway—JUN—bone cancer	0.000803	0.00948	CbGpPWpGaD
Estropipate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000788	0.0093	CbGpPWpGaD
Estropipate—ESR1—FOXM1 transcription factor network—CHEK2—bone cancer	0.000776	0.00916	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—WT1—bone cancer	0.000759	0.00896	CbGpPWpGaD
Estropipate—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000719	0.00849	CbGpPWpGaD
Estropipate—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000704	0.00831	CbGpPWpGaD
Estropipate—ESR1—Estrogen signaling pathway—BRAF—bone cancer	0.000698	0.00824	CbGpPWpGaD
Estropipate—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000677	0.00799	CbGpPWpGaD
Estropipate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000673	0.00795	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000658	0.00777	CbGpPWpGaD
Estropipate—ESR1—FOXM1 transcription factor network—BRCA2—bone cancer	0.000657	0.00776	CbGpPWpGaD
Estropipate—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000654	0.00772	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—bone cancer	0.000645	0.00762	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000627	0.00741	CbGpPWpGaD
Estropipate—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000626	0.0074	CbGpPWpGaD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	0.000618	0.0073	CbGpPWpGaD
Estropipate—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000601	0.0071	CbGpPWpGaD
Estropipate—Cystitis noninfective—Doxorubicin—bone cancer	0.000588	0.00305	CcSEcCtD
Estropipate—ESR1—Generic Transcription Pathway—ZNF77—bone cancer	0.000588	0.00694	CbGpPWpGaD
Estropipate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—bone cancer	0.000584	0.00689	CbGpPWpGaD
Estropipate—Thrombophlebitis—Methotrexate—bone cancer	0.000583	0.00303	CcSEcCtD
Estropipate—Cystitis—Doxorubicin—bone cancer	0.000581	0.00302	CcSEcCtD
Estropipate—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000578	0.00683	CbGpPWpGaD
Estropipate—Immune system disorder—Cisplatin—bone cancer	0.000575	0.00298	CcSEcCtD
Estropipate—Mediastinal disorder—Cisplatin—bone cancer	0.000573	0.00298	CcSEcCtD
Estropipate—Fluid retention—Doxorubicin—bone cancer	0.000572	0.00297	CcSEcCtD
Estropipate—Hypertonia—Epirubicin—bone cancer	0.00057	0.00296	CcSEcCtD
Estropipate—Vaginal infection—Doxorubicin—bone cancer	0.000568	0.00295	CcSEcCtD
Estropipate—Alopecia—Cisplatin—bone cancer	0.000562	0.00292	CcSEcCtD
Estropipate—ESR2—Gene Expression—ZNF77—bone cancer	0.000561	0.00663	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00056	0.00661	CbGpPWpGaD
Estropipate—Malnutrition—Cisplatin—bone cancer	0.000554	0.00287	CcSEcCtD
Estropipate—Erythema—Cisplatin—bone cancer	0.000554	0.00287	CcSEcCtD
Estropipate—Cramps of lower extremities—Doxorubicin—bone cancer	0.000553	0.00287	CcSEcCtD
Estropipate—Flatulence—Cisplatin—bone cancer	0.000546	0.00283	CcSEcCtD
Estropipate—Thrombophlebitis—Epirubicin—bone cancer	0.000546	0.00283	CcSEcCtD
Estropipate—Neoplasm—Doxorubicin—bone cancer	0.000544	0.00282	CcSEcCtD
Estropipate—Bladder pain—Doxorubicin—bone cancer	0.000544	0.00282	CcSEcCtD
Estropipate—Hepatic function abnormal—Epirubicin—bone cancer	0.00054	0.0028	CcSEcCtD
Estropipate—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000536	0.00633	CbGpPWpGaD
Estropipate—Visual disturbance—Methotrexate—bone cancer	0.000533	0.00276	CcSEcCtD
Estropipate—Muscle spasms—Cisplatin—bone cancer	0.000533	0.00276	CcSEcCtD
Estropipate—Ethinyl Estradiol—CYP3A4—bone cancer	0.000532	0.0631	CrCbGaD
Estropipate—Hypertonia—Doxorubicin—bone cancer	0.000528	0.00274	CcSEcCtD
Estropipate—Anaphylactoid reaction—Methotrexate—bone cancer	0.000522	0.00271	CcSEcCtD
Estropipate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00052	0.00613	CbGpPWpGaD
Estropipate—Cerebrovascular accident—Methotrexate—bone cancer	0.000515	0.00267	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00051	0.00602	CbGpPWpGaD
Estropipate—ESR1—Estrogen signaling pathway—JUN—bone cancer	0.000509	0.006	CbGpPWpGaD
Estropipate—Thrombophlebitis—Doxorubicin—bone cancer	0.000505	0.00262	CcSEcCtD
Estropipate—Hepatic function abnormal—Doxorubicin—bone cancer	0.0005	0.0026	CcSEcCtD
Estropipate—Dermatitis bullous—Epirubicin—bone cancer	0.000494	0.00256	CcSEcCtD
Estropipate—Purpura—Epirubicin—bone cancer	0.00049	0.00254	CcSEcCtD
Estropipate—Anaphylactoid reaction—Epirubicin—bone cancer	0.000488	0.00253	CcSEcCtD
Estropipate—ESR1—FOXM1 transcription factor network—CDK4—bone cancer	0.000488	0.00576	CbGpPWpGaD
Estropipate—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000483	0.0057	CbGpPWpGaD
Estropipate—Cerebrovascular accident—Epirubicin—bone cancer	0.000482	0.0025	CcSEcCtD
Estropipate—Irritability—Methotrexate—bone cancer	0.000482	0.0025	CcSEcCtD
Estropipate—Mood swings—Methotrexate—bone cancer	0.000478	0.00248	CcSEcCtD
Estropipate—Pain in extremity—Epirubicin—bone cancer	0.000472	0.00245	CcSEcCtD
Estropipate—Myalgia—Cisplatin—bone cancer	0.000472	0.00245	CcSEcCtD
Estropipate—Anxiety—Cisplatin—bone cancer	0.00047	0.00244	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000468	0.00243	CcSEcCtD
Estropipate—Conjugated Estrogens—CYP3A4—bone cancer	0.000465	0.0551	CrCbGaD
Estropipate—Migraine—Epirubicin—bone cancer	0.000465	0.00241	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000464	0.00548	CbGpPWpGaD
Estropipate—Estrone—CYP3A4—bone cancer	0.000464	0.055	CrCbGaD
Estropipate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00046	0.00543	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000458	0.00541	CbGpPWpGaD
Estropipate—Dermatitis bullous—Doxorubicin—bone cancer	0.000457	0.00237	CcSEcCtD
Estropipate—Breast disorder—Methotrexate—bone cancer	0.000456	0.00237	CcSEcCtD
Estropipate—Purpura—Doxorubicin—bone cancer	0.000453	0.00235	CcSEcCtD
Estropipate—Anaphylactic shock—Cisplatin—bone cancer	0.000452	0.00235	CcSEcCtD
Estropipate—Oedema—Cisplatin—bone cancer	0.000452	0.00235	CcSEcCtD
Estropipate—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000452	0.00234	CcSEcCtD
Estropipate—Infection—Cisplatin—bone cancer	0.000449	0.00233	CcSEcCtD
Estropipate—Mood swings—Epirubicin—bone cancer	0.000447	0.00232	CcSEcCtD
Estropipate—Cerebrovascular accident—Doxorubicin—bone cancer	0.000446	0.00231	CcSEcCtD
Estropipate—ESR2—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	0.000445	0.00525	CbGpPWpGaD
Estropipate—Nervous system disorder—Cisplatin—bone cancer	0.000443	0.0023	CcSEcCtD
Estropipate—Skin disorder—Cisplatin—bone cancer	0.000439	0.00228	CcSEcCtD
Estropipate—Pain in extremity—Doxorubicin—bone cancer	0.000437	0.00227	CcSEcCtD
Estropipate—Asthma—Methotrexate—bone cancer	0.000436	0.00226	CcSEcCtD
Estropipate—Migraine—Doxorubicin—bone cancer	0.00043	0.00223	CcSEcCtD
Estropipate—Pancreatitis—Methotrexate—bone cancer	0.000428	0.00222	CcSEcCtD
Estropipate—Breast disorder—Epirubicin—bone cancer	0.000427	0.00222	CcSEcCtD
Estropipate—ESR1—FOXM1 transcription factor network—RB1—bone cancer	0.000424	0.005	CbGpPWpGaD
Estropipate—Abdominal discomfort—Methotrexate—bone cancer	0.000418	0.00217	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—MMP2—bone cancer	0.000415	0.00489	CbGpPWpGaD
Estropipate—Mood swings—Doxorubicin—bone cancer	0.000414	0.00215	CcSEcCtD
Estropipate—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000414	0.00489	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000412	0.00214	CcSEcCtD
Estropipate—Abdominal distension—Epirubicin—bone cancer	0.000411	0.00213	CcSEcCtD
Estropipate—Influenza—Epirubicin—bone cancer	0.000408	0.00212	CcSEcCtD
Estropipate—Asthma—Epirubicin—bone cancer	0.000408	0.00212	CcSEcCtD
Estropipate—Dysuria—Methotrexate—bone cancer	0.000408	0.00212	CcSEcCtD
Estropipate—ESR1—FOXM1 transcription factor network—MMP2—bone cancer	0.000407	0.0048	CbGpPWpGaD
Estropipate—Paraesthesia—Cisplatin—bone cancer	0.000406	0.00211	CcSEcCtD
Estropipate—Upper respiratory tract infection—Methotrexate—bone cancer	0.000405	0.0021	CcSEcCtD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—bone cancer	0.000403	0.00476	CbGpPWpGaD
Estropipate—Pancreatitis—Epirubicin—bone cancer	0.0004	0.00208	CcSEcCtD
Estropipate—Breast disorder—Doxorubicin—bone cancer	0.000395	0.00205	CcSEcCtD
Estropipate—ESR2—Generic Transcription Pathway—NR1I2—bone cancer	0.000395	0.00466	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000394	0.00465	CbGpPWpGaD
Estropipate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000393	0.00464	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—PLAU—bone cancer	0.000393	0.00464	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—DHFR—bone cancer	0.00039	0.00461	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Cisplatin—bone cancer	0.00039	0.00203	CcSEcCtD
Estropipate—Infestation—Methotrexate—bone cancer	0.000389	0.00202	CcSEcCtD
Estropipate—Infestation NOS—Methotrexate—bone cancer	0.000389	0.00202	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000388	0.00458	CbGpPWpGaD
Estropipate—Depression—Methotrexate—bone cancer	0.000388	0.00201	CcSEcCtD
Estropipate—Pain—Cisplatin—bone cancer	0.000387	0.00201	CcSEcCtD
Estropipate—Dysuria—Epirubicin—bone cancer	0.000382	0.00198	CcSEcCtD
Estropipate—Abdominal distension—Doxorubicin—bone cancer	0.00038	0.00197	CcSEcCtD
Estropipate—Upper respiratory tract infection—Epirubicin—bone cancer	0.000379	0.00197	CcSEcCtD
Estropipate—Asthma—Doxorubicin—bone cancer	0.000378	0.00196	CcSEcCtD
Estropipate—Influenza—Doxorubicin—bone cancer	0.000378	0.00196	CcSEcCtD
Estropipate—Weight increased—Epirubicin—bone cancer	0.000372	0.00193	CcSEcCtD
Estropipate—ESR1—ATF-2 transcription factor network—CDK4—bone cancer	0.000371	0.00439	CbGpPWpGaD
Estropipate—Pancreatitis—Doxorubicin—bone cancer	0.00037	0.00192	CcSEcCtD
Estropipate—Hyperglycaemia—Epirubicin—bone cancer	0.000368	0.00191	CcSEcCtD
Estropipate—Hepatobiliary disease—Methotrexate—bone cancer	0.000368	0.00191	CcSEcCtD
Estropipate—Infestation—Epirubicin—bone cancer	0.000364	0.00189	CcSEcCtD
Estropipate—Infestation NOS—Epirubicin—bone cancer	0.000364	0.00189	CcSEcCtD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.000363	0.00429	CbGpPWpGaD
Estropipate—Body temperature increased—Cisplatin—bone cancer	0.000357	0.00185	CcSEcCtD
Estropipate—Neuropathy peripheral—Epirubicin—bone cancer	0.000357	0.00185	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—bone cancer	0.000353	0.00183	CcSEcCtD
Estropipate—Estradiol—CYP3A4—bone cancer	0.000351	0.0417	CrCbGaD
Estropipate—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000351	0.00182	CcSEcCtD
Estropipate—Pharyngitis—Methotrexate—bone cancer	0.000347	0.0018	CcSEcCtD
Estropipate—Hepatobiliary disease—Epirubicin—bone cancer	0.000344	0.00179	CcSEcCtD
Estropipate—Weight increased—Doxorubicin—bone cancer	0.000344	0.00178	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—PLAU—bone cancer	0.000343	0.00405	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—SPARC—bone cancer	0.000342	0.00404	CbGpPWpGaD
Estropipate—Sinusitis—Epirubicin—bone cancer	0.000342	0.00177	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—bone cancer	0.000341	0.00177	CcSEcCtD
Estropipate—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000339	0.004	CbGpPWpGaD
Estropipate—Infestation—Doxorubicin—bone cancer	0.000337	0.00175	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—bone cancer	0.000337	0.00175	CcSEcCtD
Estropipate—Visual impairment—Methotrexate—bone cancer	0.000337	0.00175	CcSEcCtD
Estropipate—Hypersensitivity—Cisplatin—bone cancer	0.000333	0.00173	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000332	0.00392	CbGpPWpGaD
Estropipate—Erythema multiforme—Methotrexate—bone cancer	0.00033	0.00171	CcSEcCtD
Estropipate—Neuropathy peripheral—Doxorubicin—bone cancer	0.00033	0.00171	CcSEcCtD
Estropipate—Rhinitis—Epirubicin—bone cancer	0.000328	0.0017	CcSEcCtD
Estropipate—Eye disorder—Methotrexate—bone cancer	0.000326	0.00169	CcSEcCtD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000326	0.00385	CbGpPWpGaD
Estropipate—Asthenia—Cisplatin—bone cancer	0.000324	0.00168	CcSEcCtD
Estropipate—Pharyngitis—Epirubicin—bone cancer	0.000324	0.00168	CcSEcCtD
Estropipate—Cardiac disorder—Methotrexate—bone cancer	0.000324	0.00168	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000324	0.00382	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—RB1—bone cancer	0.000323	0.00381	CbGpPWpGaD
Estropipate—Oedema peripheral—Epirubicin—bone cancer	0.000322	0.00167	CcSEcCtD
Estropipate—Hepatobiliary disease—Doxorubicin—bone cancer	0.000319	0.00165	CcSEcCtD
Estropipate—Angiopathy—Methotrexate—bone cancer	0.000317	0.00164	CcSEcCtD
Estropipate—Sinusitis—Doxorubicin—bone cancer	0.000316	0.00164	CcSEcCtD
Estropipate—Immune system disorder—Methotrexate—bone cancer	0.000315	0.00164	CcSEcCtD
Estropipate—Visual impairment—Epirubicin—bone cancer	0.000315	0.00163	CcSEcCtD
Estropipate—Mediastinal disorder—Methotrexate—bone cancer	0.000315	0.00163	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	0.000312	0.00368	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—MMP2—bone cancer	0.00031	0.00366	CbGpPWpGaD
Estropipate—Diarrhoea—Cisplatin—bone cancer	0.000309	0.00161	CcSEcCtD
Estropipate—Erythema multiforme—Epirubicin—bone cancer	0.000309	0.0016	CcSEcCtD
Estropipate—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000309	0.00365	CbGpPWpGaD
Estropipate—Alopecia—Methotrexate—bone cancer	0.000309	0.0016	CcSEcCtD
Estropipate—Mental disorder—Methotrexate—bone cancer	0.000306	0.00159	CcSEcCtD
Estropipate—Eye disorder—Epirubicin—bone cancer	0.000305	0.00158	CcSEcCtD
Estropipate—Malnutrition—Methotrexate—bone cancer	0.000304	0.00158	CcSEcCtD
Estropipate—Erythema—Methotrexate—bone cancer	0.000304	0.00158	CcSEcCtD
Estropipate—Cardiac disorder—Epirubicin—bone cancer	0.000303	0.00157	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—bone cancer	0.000303	0.00157	CcSEcCtD
Estropipate—ESR1—FOXA1 transcription factor network—JUN—bone cancer	0.000303	0.00357	CbGpPWpGaD
Estropipate—Pharyngitis—Doxorubicin—bone cancer	0.0003	0.00156	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—bone cancer	0.000298	0.00155	CcSEcCtD
Estropipate—Angiopathy—Epirubicin—bone cancer	0.000296	0.00154	CcSEcCtD
Estropipate—Immune system disorder—Epirubicin—bone cancer	0.000295	0.00153	CcSEcCtD
Estropipate—Mediastinal disorder—Epirubicin—bone cancer	0.000295	0.00153	CcSEcCtD
Estropipate—Back pain—Methotrexate—bone cancer	0.000294	0.00153	CcSEcCtD
Estropipate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000292	0.00345	CbGpPWpGaD
Estropipate—Visual impairment—Doxorubicin—bone cancer	0.000291	0.00151	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.00029	0.00342	CbGpPWpGaD
Estropipate—Alopecia—Epirubicin—bone cancer	0.000289	0.0015	CcSEcCtD
Estropipate—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000288	0.0034	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000288	0.0034	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000288	0.0034	CbGpPWpGaD
Estropipate—Vomiting—Cisplatin—bone cancer	0.000287	0.00149	CcSEcCtD
Estropipate—Mental disorder—Epirubicin—bone cancer	0.000286	0.00149	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—bone cancer	0.000286	0.00148	CcSEcCtD
Estropipate—Rash—Cisplatin—bone cancer	0.000285	0.00148	CcSEcCtD
Estropipate—Dermatitis—Cisplatin—bone cancer	0.000285	0.00148	CcSEcCtD
Estropipate—Malnutrition—Epirubicin—bone cancer	0.000284	0.00148	CcSEcCtD
Estropipate—Erythema—Epirubicin—bone cancer	0.000284	0.00148	CcSEcCtD
Estropipate—ESR1—Gene Expression—ZNF77—bone cancer	0.000283	0.00334	CbGpPWpGaD
Estropipate—Eye disorder—Doxorubicin—bone cancer	0.000283	0.00147	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000282	0.00333	CbGpPWpGaD
Estropipate—Cardiac disorder—Doxorubicin—bone cancer	0.000281	0.00146	CcSEcCtD
Estropipate—Flatulence—Epirubicin—bone cancer	0.00028	0.00145	CcSEcCtD
Estropipate—Tension—Epirubicin—bone cancer	0.000279	0.00145	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000279	0.00329	CbGpPWpGaD
Estropipate—Nervousness—Epirubicin—bone cancer	0.000276	0.00143	CcSEcCtD
Estropipate—Back pain—Epirubicin—bone cancer	0.000275	0.00143	CcSEcCtD
Estropipate—Angiopathy—Doxorubicin—bone cancer	0.000274	0.00142	CcSEcCtD
Estropipate—ESR2—Gene Expression—FUS—bone cancer	0.000274	0.00324	CbGpPWpGaD
Estropipate—Muscle spasms—Epirubicin—bone cancer	0.000273	0.00142	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—bone cancer	0.000273	0.00142	CcSEcCtD
Estropipate—Vertigo—Methotrexate—bone cancer	0.000273	0.00142	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—bone cancer	0.000273	0.00141	CcSEcCtD
Estropipate—Nausea—Cisplatin—bone cancer	0.000269	0.00139	CcSEcCtD
Estropipate—Alopecia—Doxorubicin—bone cancer	0.000267	0.00139	CcSEcCtD
Estropipate—Cough—Methotrexate—bone cancer	0.000265	0.00138	CcSEcCtD
Estropipate—Mental disorder—Doxorubicin—bone cancer	0.000265	0.00137	CcSEcCtD
Estropipate—Erythema—Doxorubicin—bone cancer	0.000263	0.00137	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—bone cancer	0.000263	0.00137	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—bone cancer	0.000259	0.00135	CcSEcCtD
Estropipate—Myalgia—Methotrexate—bone cancer	0.000259	0.00134	CcSEcCtD
Estropipate—Arthralgia—Methotrexate—bone cancer	0.000259	0.00134	CcSEcCtD
Estropipate—Tension—Doxorubicin—bone cancer	0.000258	0.00134	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000257	0.00304	CbGpPWpGaD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000257	0.00133	CcSEcCtD
Estropipate—Nervousness—Doxorubicin—bone cancer	0.000256	0.00133	CcSEcCtD
Estropipate—Vertigo—Epirubicin—bone cancer	0.000256	0.00133	CcSEcCtD
Estropipate—Back pain—Doxorubicin—bone cancer	0.000255	0.00132	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—bone cancer	0.000253	0.00131	CcSEcCtD
Estropipate—Palpitations—Epirubicin—bone cancer	0.000251	0.0013	CcSEcCtD
Estropipate—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00025	0.00295	CbGpPWpGaD
Estropipate—Cough—Epirubicin—bone cancer	0.000248	0.00129	CcSEcCtD
Estropipate—Anaphylactic shock—Methotrexate—bone cancer	0.000248	0.00129	CcSEcCtD
Estropipate—Infection—Methotrexate—bone cancer	0.000246	0.00128	CcSEcCtD
Estropipate—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000246	0.00291	CbGpPWpGaD
Estropipate—Nervous system disorder—Methotrexate—bone cancer	0.000243	0.00126	CcSEcCtD
Estropipate—Myalgia—Epirubicin—bone cancer	0.000242	0.00126	CcSEcCtD
Estropipate—Arthralgia—Epirubicin—bone cancer	0.000242	0.00126	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000242	0.00285	CbGpPWpGaD
Estropipate—Anxiety—Epirubicin—bone cancer	0.000241	0.00125	CcSEcCtD
Estropipate—Skin disorder—Methotrexate—bone cancer	0.000241	0.00125	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000241	0.00125	CcSEcCtD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.00024	0.00283	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—JUN—bone cancer	0.000239	0.00283	CbGpPWpGaD
Estropipate—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000237	0.0028	CbGpPWpGaD
Estropipate—Vertigo—Doxorubicin—bone cancer	0.000236	0.00123	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000236	0.00279	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000234	0.00276	CbGpPWpGaD
Estropipate—Palpitations—Doxorubicin—bone cancer	0.000233	0.00121	CcSEcCtD
Estropipate—Oedema—Epirubicin—bone cancer	0.000232	0.0012	CcSEcCtD
Estropipate—Anaphylactic shock—Epirubicin—bone cancer	0.000232	0.0012	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000231	0.00273	CbGpPWpGaD
Estropipate—Infection—Epirubicin—bone cancer	0.000231	0.0012	CcSEcCtD
Estropipate—Cough—Doxorubicin—bone cancer	0.00023	0.00119	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.00023	0.00271	CbGpPWpGaD
Estropipate—Nervous system disorder—Epirubicin—bone cancer	0.000228	0.00118	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000226	0.00117	CcSEcCtD
Estropipate—Skin disorder—Epirubicin—bone cancer	0.000226	0.00117	CcSEcCtD
Estropipate—Insomnia—Methotrexate—bone cancer	0.000224	0.00116	CcSEcCtD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	0.000224	0.00265	CbGpPWpGaD
Estropipate—Arthralgia—Doxorubicin—bone cancer	0.000224	0.00116	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—bone cancer	0.000224	0.00116	CcSEcCtD
Estropipate—Anxiety—Doxorubicin—bone cancer	0.000223	0.00116	CcSEcCtD
Estropipate—Paraesthesia—Methotrexate—bone cancer	0.000223	0.00116	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000223	0.00115	CcSEcCtD
Estropipate—Somnolence—Methotrexate—bone cancer	0.000221	0.00114	CcSEcCtD
Estropipate—Dyspepsia—Methotrexate—bone cancer	0.000218	0.00113	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—JUN—bone cancer	0.000218	0.00257	CbGpPWpGaD
Estropipate—Anaphylactic shock—Doxorubicin—bone cancer	0.000215	0.00111	CcSEcCtD
Estropipate—Oedema—Doxorubicin—bone cancer	0.000215	0.00111	CcSEcCtD
Estropipate—Gastrointestinal disorder—Methotrexate—bone cancer	0.000214	0.00111	CcSEcCtD
Estropipate—Fatigue—Methotrexate—bone cancer	0.000214	0.00111	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—JUN—bone cancer	0.000214	0.00252	CbGpPWpGaD
Estropipate—Infection—Doxorubicin—bone cancer	0.000213	0.00111	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000213	0.00252	CbGpPWpGaD
Estropipate—Pain—Methotrexate—bone cancer	0.000212	0.0011	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000212	0.0011	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—bone cancer	0.000211	0.00109	CcSEcCtD
Estropipate—Insomnia—Epirubicin—bone cancer	0.00021	0.00109	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—JUN—bone cancer	0.000209	0.00246	CbGpPWpGaD
Estropipate—Skin disorder—Doxorubicin—bone cancer	0.000209	0.00108	CcSEcCtD
Estropipate—Paraesthesia—Epirubicin—bone cancer	0.000208	0.00108	CcSEcCtD
Estropipate—Somnolence—Epirubicin—bone cancer	0.000206	0.00107	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000206	0.00243	CbGpPWpGaD
Estropipate—Dyspepsia—Epirubicin—bone cancer	0.000204	0.00106	CcSEcCtD
Estropipate—ESR1—LKB1 signaling events—TP53—bone cancer	0.000204	0.0024	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—MMP9—bone cancer	0.000203	0.0024	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Methotrexate—bone cancer	0.000203	0.00105	CcSEcCtD
Estropipate—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000202	0.00239	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Epirubicin—bone cancer	0.0002	0.00104	CcSEcCtD
Estropipate—Fatigue—Epirubicin—bone cancer	0.0002	0.00104	CcSEcCtD
Estropipate—ESR1—Generic Transcription Pathway—NR1I2—bone cancer	0.000199	0.00235	CbGpPWpGaD
Estropipate—Pain—Epirubicin—bone cancer	0.000199	0.00103	CcSEcCtD
Estropipate—Constipation—Epirubicin—bone cancer	0.000199	0.00103	CcSEcCtD
Estropipate—Urticaria—Methotrexate—bone cancer	0.000197	0.00102	CcSEcCtD
Estropipate—Body temperature increased—Methotrexate—bone cancer	0.000196	0.00102	CcSEcCtD
Estropipate—Abdominal pain—Methotrexate—bone cancer	0.000196	0.00102	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000196	0.00102	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000196	0.00231	CbGpPWpGaD
Estropipate—Insomnia—Doxorubicin—bone cancer	0.000194	0.00101	CcSEcCtD
Estropipate—Paraesthesia—Doxorubicin—bone cancer	0.000193	0.001	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—bone cancer	0.000191	0.000991	CcSEcCtD
Estropipate—ESR2—Gene Expression—NR1I2—bone cancer	0.00019	0.00224	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Epirubicin—bone cancer	0.00019	0.000985	CcSEcCtD
Estropipate—Dyspepsia—Doxorubicin—bone cancer	0.000189	0.000981	CcSEcCtD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000186	0.00219	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000185	0.00219	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000185	0.000962	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—bone cancer	0.000185	0.000961	CcSEcCtD
Estropipate—Urticaria—Epirubicin—bone cancer	0.000184	0.000957	CcSEcCtD
Estropipate—Pain—Doxorubicin—bone cancer	0.000184	0.000953	CcSEcCtD
Estropipate—Constipation—Doxorubicin—bone cancer	0.000184	0.000953	CcSEcCtD
Estropipate—Body temperature increased—Epirubicin—bone cancer	0.000184	0.000952	CcSEcCtD
Estropipate—Abdominal pain—Epirubicin—bone cancer	0.000184	0.000952	CcSEcCtD
Estropipate—Hypersensitivity—Methotrexate—bone cancer	0.000183	0.000948	CcSEcCtD
Estropipate—Asthenia—Methotrexate—bone cancer	0.000178	0.000924	CcSEcCtD
Estropipate—SLC22A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000176	0.00208	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Doxorubicin—bone cancer	0.000176	0.000912	CcSEcCtD
Estropipate—Pruritus—Methotrexate—bone cancer	0.000176	0.000911	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000175	0.00207	CbGpPWpGaD
Estropipate—Hypersensitivity—Epirubicin—bone cancer	0.000171	0.000888	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—bone cancer	0.000171	0.000886	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—bone cancer	0.00017	0.000881	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—bone cancer	0.00017	0.000881	CcSEcCtD
Estropipate—Diarrhoea—Methotrexate—bone cancer	0.00017	0.000881	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—EGFR—bone cancer	0.000168	0.00198	CbGpPWpGaD
Estropipate—Asthenia—Epirubicin—bone cancer	0.000167	0.000864	CcSEcCtD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000166	0.00197	CbGpPWpGaD
Estropipate—Pruritus—Epirubicin—bone cancer	0.000164	0.000852	CcSEcCtD
Estropipate—Dizziness—Methotrexate—bone cancer	0.000164	0.000851	CcSEcCtD
Estropipate—ESR1—Signaling by ERBB4—KIT—bone cancer	0.000164	0.00194	CbGpPWpGaD
Estropipate—Diarrhoea—Epirubicin—bone cancer	0.000159	0.000824	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—bone cancer	0.000158	0.000821	CcSEcCtD
Estropipate—Vomiting—Methotrexate—bone cancer	0.000158	0.000819	CcSEcCtD
Estropipate—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000157	0.00186	CbGpPWpGaD
Estropipate—Rash—Methotrexate—bone cancer	0.000156	0.000812	CcSEcCtD
Estropipate—Dermatitis—Methotrexate—bone cancer	0.000156	0.000811	CcSEcCtD
Estropipate—Headache—Methotrexate—bone cancer	0.000155	0.000806	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000155	0.00183	CbGpPWpGaD
Estropipate—Asthenia—Doxorubicin—bone cancer	0.000154	0.0008	CcSEcCtD
Estropipate—Dizziness—Epirubicin—bone cancer	0.000154	0.000797	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000152	0.0018	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000152	0.0018	CbGpPWpGaD
Estropipate—Pruritus—Doxorubicin—bone cancer	0.000152	0.000789	CcSEcCtD
Estropipate—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000152	0.00179	CbGpPWpGaD
Estropipate—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.00015	0.00177	CbGpPWpGaD
Estropipate—Vomiting—Epirubicin—bone cancer	0.000148	0.000766	CcSEcCtD
Estropipate—Nausea—Methotrexate—bone cancer	0.000147	0.000765	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—bone cancer	0.000147	0.000763	CcSEcCtD
Estropipate—Rash—Epirubicin—bone cancer	0.000146	0.00076	CcSEcCtD
Estropipate—Dermatitis—Epirubicin—bone cancer	0.000146	0.000759	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000146	0.00172	CbGpPWpGaD
Estropipate—Headache—Epirubicin—bone cancer	0.000145	0.000755	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000145	0.00171	CbGpPWpGaD
Estropipate—Dizziness—Doxorubicin—bone cancer	0.000142	0.000737	CcSEcCtD
Estropipate—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000142	0.00168	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—EIF2S1—bone cancer	0.00014	0.00166	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000139	0.00164	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—FUS—bone cancer	0.000138	0.00163	CbGpPWpGaD
Estropipate—Nausea—Epirubicin—bone cancer	0.000138	0.000716	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—TP53—bone cancer	0.000138	0.00163	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—NDUFA12—bone cancer	0.000138	0.00163	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000137	0.00162	CbGpPWpGaD
Estropipate—Vomiting—Doxorubicin—bone cancer	0.000137	0.000709	CcSEcCtD
Estropipate—Rash—Doxorubicin—bone cancer	0.000135	0.000703	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—bone cancer	0.000135	0.000702	CcSEcCtD
Estropipate—Headache—Doxorubicin—bone cancer	0.000135	0.000698	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.00013	0.00153	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—MDM2—bone cancer	0.000129	0.00152	CbGpPWpGaD
Estropipate—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000128	0.00151	CbGpPWpGaD
Estropipate—Nausea—Doxorubicin—bone cancer	0.000128	0.000662	CcSEcCtD
Estropipate—CYP2C9—Biological oxidations—CYP3A4—bone cancer	0.000126	0.00149	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000126	0.00149	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	0.000124	0.00147	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000123	0.00146	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000122	0.00145	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—EZH2—bone cancer	0.000122	0.00144	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000118	0.00139	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	0.000116	0.00137	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—NT5C3A—bone cancer	0.000114	0.00135	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000113	0.00133	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000112	0.00132	CbGpPWpGaD
Estropipate—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.00011	0.00129	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—GSTP1—bone cancer	0.000108	0.00127	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000108	0.00127	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—CYP3A4—bone cancer	0.000108	0.00127	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	0.000106	0.00125	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	0.000106	0.00125	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000104	0.00122	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000102	0.0012	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	9.7e-05	0.00115	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	9.7e-05	0.00115	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—NR1I2—bone cancer	9.58e-05	0.00113	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	9.36e-05	0.00111	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	9.35e-05	0.0011	CbGpPWpGaD
Estropipate—ALB—Metabolism—NDUFA12—bone cancer	9.21e-05	0.00109	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—GSTP1—bone cancer	9.2e-05	0.00109	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	9.07e-05	0.00107	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—EGFR—bone cancer	8.87e-05	0.00105	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—EGFR—bone cancer	8.83e-05	0.00104	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TP53—bone cancer	8.72e-05	0.00103	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—BRAF—bone cancer	8.56e-05	0.00101	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SPARC—bone cancer	7.82e-05	0.000923	CbGpPWpGaD
Estropipate—ALB—Metabolism—NT5C3A—bone cancer	7.63e-05	0.000901	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NDUFA12—bone cancer	7.54e-05	0.00089	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TP53—bone cancer	7.45e-05	0.00088	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	7.35e-05	0.000868	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GRM4—bone cancer	7.19e-05	0.000848	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RGS1—bone cancer	7.19e-05	0.000848	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—MDM2—bone cancer	7.17e-05	0.000847	CbGpPWpGaD
Estropipate—ALB—Hemostasis—GNA11—bone cancer	7.15e-05	0.000844	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—GSTP1—bone cancer	7.1e-05	0.000838	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—EIF2S1—bone cancer	7.08e-05	0.000836	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	7e-05	0.000826	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL3—bone cancer	6.48e-05	0.000765	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NDUFA12—bone cancer	6.44e-05	0.000761	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NT5C3A—bone cancer	6.25e-05	0.000738	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GRM1—bone cancer	6.23e-05	0.000736	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	6.17e-05	0.000729	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—EZH2—bone cancer	6.15e-05	0.000726	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NT5C3A—bone cancer	5.34e-05	0.00063	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ENO2—bone cancer	5e-05	0.00059	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NDUFA12—bone cancer	4.97e-05	0.000587	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—DHFR—bone cancer	4.64e-05	0.000548	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SMO—bone cancer	4.39e-05	0.000518	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GNA11—bone cancer	4.33e-05	0.000512	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PLAU—bone cancer	4.25e-05	0.000502	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NT5C3A—bone cancer	4.12e-05	0.000487	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GNA11—bone cancer	4.02e-05	0.000474	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP3A4—bone cancer	3.93e-05	0.000464	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ATF1—bone cancer	3.73e-05	0.000441	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL3—bone cancer	3.64e-05	0.00043	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTP1—bone cancer	3.36e-05	0.000397	CbGpPWpGaD
Estropipate—ALB—Metabolism—ENO2—bone cancer	3.34e-05	0.000395	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TGFBR2—bone cancer	3.11e-05	0.000368	CbGpPWpGaD
Estropipate—ALB—Metabolism—DHFR—bone cancer	3.1e-05	0.000366	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IGF1R—bone cancer	2.93e-05	0.000346	CbGpPWpGaD
Estropipate—ALB—Metabolism—GNA11—bone cancer	2.9e-05	0.000342	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ENO2—bone cancer	2.74e-05	0.000323	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP3A4—bone cancer	2.63e-05	0.00031	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.62e-05	0.000309	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—DHFR—bone cancer	2.54e-05	0.0003	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GNA11—bone cancer	2.37e-05	0.00028	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ENO2—bone cancer	2.34e-05	0.000276	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTP1—bone cancer	2.25e-05	0.000265	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—DHFR—bone cancer	2.17e-05	0.000256	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP3A4—bone cancer	2.15e-05	0.000254	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.14e-05	0.000253	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KIT—bone cancer	2.12e-05	0.000251	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GNA11—bone cancer	2.03e-05	0.000239	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—BRAF—bone cancer	2e-05	0.000236	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTP1—bone cancer	1.84e-05	0.000217	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP3A4—bone cancer	1.84e-05	0.000217	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.83e-05	0.000216	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ENO2—bone cancer	1.81e-05	0.000213	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTGS2—bone cancer	1.74e-05	0.000206	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—bone cancer	1.71e-05	0.000202	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—DHFR—bone cancer	1.67e-05	0.000198	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MDM2—bone cancer	1.67e-05	0.000198	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTP1—bone cancer	1.57e-05	0.000186	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GNA11—bone cancer	1.57e-05	0.000185	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JUN—bone cancer	1.45e-05	0.000172	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MMP9—bone cancer	1.41e-05	0.000167	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTP1—bone cancer	1.21e-05	0.000143	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTGS2—bone cancer	1.16e-05	0.000138	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGFR—bone cancer	1.14e-05	0.000135	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—bone cancer	9.6e-06	0.000113	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTGS2—bone cancer	9.53e-06	0.000113	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTGS2—bone cancer	8.15e-06	9.62e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTGS2—bone cancer	6.29e-06	7.42e-05	CbGpPWpGaD
